MedTrace Logo

Evaluation of Primex's PGX Assay to Assess the Clinical Utility of Pharmacogenomics

NCT02336269 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100000

Last updated 2015-01-12

No results posted yet for this study

Summary

Primex's PGX assay is an in vitro, semi automated assay, intended for the determination of certain genes involved in drug metabolism utilizing buccal swabs. Detection of certain genotypes is used as an aid in the selection of appropriate medications based on the individuals' specific genotype and should be used in conjunction with other clinical information. The results from this tests constitutes one parameter in a multicriterion medication selection process, encompassing both clinical and laboratory-based assessments.

Conditions

  • Patients on Medications Metabolized Via CYP450

Sponsors & Collaborators

  • Research & Development Institute, Inc.

    collaborator INDUSTRY

  • Primex Clinical Laboratories, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2017-10-31
Completion
2019-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02336269 on ClinicalTrials.gov